Hospitals & Diagnostics · Hospital/Nursing Management · NSE: KMCSHIL · data 2026-10-30
KMC Speciality Hospitals (India) Limited
In plain words
Price: 20.0% below its 52-week high of ₹185.5.
Delivery: 33.6% of traded shares were kept for delivery over the last 10 sessions, against 40.4% over the last 52.
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹331 cr |
| Net profit (last 12 months) | ₹56 cr |
| Sales growth, 3 years (yearly) | 25.2% |
| Profit growth, 3 years (yearly) | 20.5% |
Smart-money activity
18/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 13/30: Delivery 28.5% over the last 20 sessions vs 16.0% in the 40 before (1.78x); shares delivered per day 1.05x usual; 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Common questions
Is KMC Speciality Hospitals (India) Limited debt-free?
Its latest reported debt-to-equity ratio is 0.4.
What is KMC Speciality Hospitals (India) Limited's P/E ratio?
About 43.4, based on the last 12 months' earnings and a price of ₹148.39 (data 2026-10-30).
What is the 52-week high and low of KMC Speciality Hospitals (India) Limited?
The 52-week high is ₹185.5 and the 52-week low is ₹128.48.
Similar companies
Artemis Medicare Services Ltd. (ARTEMISMED) · Indraprastha Medical Corporation Limited (INDRAMEDCO) · Gujarat Kidney & Super Speciality Ltd. (GKSL) · Shalby Ltd. (SHALBY) · GPT Healthcare Limited (GPTHEALTH)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open KMCSHIL in NSE Scanner →